What is Epsilon Healthcare Limited (HDRPF)?

Epsilon Healthcare Limited (HDRPF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of HDRPF?

The current price of HDRPF is $0.01. Prices are updated in real time on Stocks360.

What is HDRPF's price-to-earnings (PE) ratio?

HDRPF's trailing twelve-month PE ratio is 66.67, based on current price and earnings per share data available on Stocks360.

What is HDRPF's market capitalization?

HDRPF's market capitalization is $3,891,040.00, placing it in the small-cap tier.

Epsilon Healthcare Limited (HDRPF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.01

Market Cap

$3.89M

PE (TTM)

66.67

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.75

Day Range

$0.00 – $0.01

52-wk Range

$0.00 – $0.01

Avg Volume

N/A

Volume

8.00K

Epsilon Healthcare Limited (HDRPF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $3.89M. Trailing PE 66.67. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.00 2026-10-26 · $0.01 (+614.29%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Epsilon Healthcare Limited

Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant. Established in 2016, the firm is headquartered in Sydney, Australia. Epsilon Healthcare Limited adopted its current identity in February 2021, having previously been known as THC Global Group Limited.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	66.67×
P/S (TTM)	0.38×
P/B	2.01×
PEG	0.16×
P/FCF (TTM)	7.98×
EV / EBITDA	-21.88×
EV / Sales	0.75×
Earnings Yield	1.24%
Free Cash Flow Yield	12.54%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$15.19M
Revenue (TTM)	$20.37M
Net Income (TTM)	$96.58K
Free Cash Flow (TTM)	$1.94M
Net Debt	$7.40M
Working Capital	-$1.05M
Gross Margin	33.98%
Operating Margin	-7.11%
Net Margin	0.47%
Return on Equity	3.34%
Return on Invested Capital	-9.85%